Merger ups & downs
Restructuring in Germany is slowly progressing, with companies retooling, spinning out, selling assets and merging. But while one new merger was announced last week, another fell apart - illustrating how difficult it often is to put two companies together.
The merger between neurological play Biofrontera Pharmaceuticals Holding AG and chemistry company Kiadis B.V., which was announced in February, was called off last week after months of negotiations. The transaction, which would